tirzepatide monitoring TimesG | A new study has highlighted the importance of older adults taking GLP-1 weight-loss medications, including Eli Lilly's Zepbound Tirzepatide on ingestive behavior in
Description
The standard titration schedule from 2.5 mg to 15 mg is the same regardless of whether someone weighs 180 pounds or 350 pounds
The problem is that most people respond to nausea by drinking less, not more
A tirzepatide vial is generally good for up to six months when stored correctly in a commercial refrigerator
Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb
Most cases are mild and don't lead to discontinuation
The range is wide because individual variation is significant at this point
